Anika Therapeutics Ownership | Who Owns Anika Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Anika Therapeutics Ownership Summary

Anika Therapeutics is owned by 13.55% institutional investors, 4.88% insiders, and 81.56% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 12.15% of ANIK shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.10% of its assets in Anika Therapeutics shares.

ANIK Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Anika Therapeutics	13.55%	4.88%	81.56%
Sector	Healthcare Stocks	42.53%	10.81%	46.67%
Industry	Medical Device Stocks	37.80%	10.03%	52.17%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	1.74M	12.15%	$16.37M
Trigran investments	1.62M	11.31%	$15.24M
Blackrock	1.61M	10.93%	$40.70M
Caligan partners lp	1.44M	10.01%	$13.49M
Vanguard group	780.66K	5.45%	$7.34M
Acadian asset management	632.79K	4.42%	$5.94M
Dimensional fund advisors lp	601.16K	4.19%	$5.65M
Capital management corp /va	551.25K	3.85%	$5.18M
Boothbay fund management	539.64K	3.77%	$5.07M
Renaissance	533.02K	3.72%	$5.01M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Trigran investments	1.62M	2.76%	$15.24M
Caligan partners lp	1.44M	1.77%	$13.49M
Cove street capital	101.96K	1.25%	$958.39K
Capital management corp /va	551.25K	0.81%	$5.18M
Diker management	56.84K	0.43%	$534.29K
Pharvision advisers	41.39K	0.22%	$389.03K
Virtus fund advisers	2.72K	0.14%	$44.84K
Globeflex capital l p	87.60K	0.13%	$823.44K
Ironwood investment management	28.20K	0.12%	$265.05K
Williams & novak	10.84K	0.08%	$101.90K

Top Buyers

Holder	Shares	% Assets	Change
Morgan stanley	394.74K	0.00%	286.36K
Blackrock funding, inc. /de	1.74M	0.00%	213.48K
Capital management corp /va	551.25K	0.81%	142.40K
Two sigma investments, lp	79.92K	0.00%	79.92K
Acadian asset management	632.79K	0.01%	57.15K

Top Sellers

Holder	Shares	% Assets	Change
Opaleye management	-	-	-588.80K
Alta fundamental advisers	-	-	-454.94K
Trigran investments	1.62M	2.76%	-415.30K
Stonepine capital management	-	-	-190.59K
Meros investment management, lp	-	-	-173.49K

New Positions

Holder	Shares	% Assets	Change	Value
Two sigma investments, lp	79.92K	0.00%	79.92K	$751.26K
Assenagon asset management	45.84K	0.00%	45.84K	$430.92K
Trexquant investment lp	44.69K	0.00%	44.69K	$420.10K
Gsa capital partners llp	41.74K	0.03%	41.74K	$392.00K
Pharvision advisers	41.39K	0.22%	41.39K	$389.03K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-3.00
Assetmark	-3.00
Ifp advisors	-4.00
Hexagon capital partners	-8.00
Rothschild investment	-10.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	39	-61.39%	1,942,121	-84.69%	13	0.17%	25	-54.55%	8	-74.19%
Jun 30, 2025	101	-6.48%	12,685,036	3.92%	88	1.21%	54	12.50%	31	-24.39%
Mar 31, 2025	109	-1.80%	12,677,819	1.18%	88	1.23%	48	-11.11%	42	7.69%
Dec 31, 2024	110	-10.57%	12,521,428	-4.37%	84	1.08%	53	8.16%	39	-18.75%
Sep 30, 2024	123	6.96%	13,093,709	-1.09%	88	1.11%	49	-2.00%	48	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	439.41K	3.10%	-
Vanguard Total Stock Mkt Idx Inv	429.93K	2.98%	-9.48K
iShares Russell 2000 ETF	304.99K	2.12%	-
CMC SMID	249.46K	1.74%	32.73K
Vanguard Institutional Extnd Mkt Idx Tr	164.18K	1.14%	-74.81K
CMC All-Cap Growth	126.64K	0.88%	34.85K
Fidelity Small Cap Index	124.27K	0.86%	-6.28K
Franklin Mutual Small-Mid Cap Val A	120.97K	0.83%	-
DFA US Targeted Value I	112.34K	0.78%	-
iShares Russell 2000 Value ETF	108.09K	0.75%	-

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	-	-
2024 Q3	-	-
2024 Q2	-	-

ANIK Ownership FAQ

Who Owns Anika Therapeutics?

Anika Therapeutics shareholders are primarily institutional investors at 13.55%, followed by 4.88% insiders and 81.57% retail investors. The average institutional ownership in Anika Therapeutics's industry, Medical Device Stocks, is 37.80%, which Anika Therapeutics falls below.

Who owns the most shares of Anika Therapeutics?

Anika Therapeutics’s largest shareholders are Blackrock funding, inc. /de (1.74M shares, 12.15%), Trigran investments (1.62M shares, 11.31%), and Blackrock (1.61M shares, 10.93%). Together, they hold 34.40% of Anika Therapeutics’s total shares outstanding.

Does Blackrock own Anika Therapeutics?

Yes, BlackRock owns 10.93% of Anika Therapeutics, totaling 1.61M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 40.7M$. In the last quarter, BlackRock increased its holdings by 45.79K shares, a 2.93% change.

Who is Anika Therapeutics’s biggest shareholder by percentage of total assets invested?

Trigran investments is Anika Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.76% of its assets in 1.62M Anika Therapeutics shares, valued at 15.24M$.

Who is the top mutual fund holder of Anika Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Anika Therapeutics shares, with 3.10% of its total shares outstanding invested in 439.41K Anika Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools